TROG 99.03

Primary sponsor: Trans Tasman Radiation Oncology Group (TROG)
Collaborating groups: ALLG (NHLLOW 5); Princess Margaret Hospital, Toronto

Title

Radiotherapy versus radiotherapy plus chemotherapy in early stage follicular lymphoma

Summary

For patients with stage I and II low grade follicular lymphoma radiotherapy will cure 40-50% of cases. This study is comparing standard therapy (radiotherapy) and investigational therapy (radiotherapy plus chemotherapy) to see if adding chemotherapy extends the time until the lymphoma progresses in those patient that will not be cured.

Final accrual

150

Trial Status

Closed to follow-up, July 2012

Trial chairperson

A/Prof Michael Mac Manus, Peter MacCallum Cancer Centre, VIC

Trial contact

Ms Bev McClure
Centre for Biostatistics and Clinical Trials (BaCT)
Email: Bev.McClure@petermac.org
Tel: +61 3 9656 5142

Further information

TROG 99.03 on Australian Cancer Trials website

Trial resources for TROG members

TROG 99.03 member page